Article Top Ad
Reading Time: 2 minutes

Jaffray Companies
(NYSE: PJC), a leading investment bank and
institutional securities firm, is pleased to announce the hiring of
Mihir Mantri and Paul Scansaroli as managing directors in its investment
banking division. Mantri will join the healthcare investment banking
group and advise life sciences companies. Scansaroli will join the
equity capital markets group with a focus on high growth companies
across the healthcare sector. Both Mantri and Scansaroli will be based
in the firm’s New York office.

Prior to joining Piper Jaffray, Mantri served as managing director and
head of life sciences at BMO Capital Markets, where he lead banking
coverage for the biotechnology sector. Earlier in his career, Mantri
worked at Jefferies & Company in healthcare investment banking. He
earned a bachelor’s degree in neuroscience from the University of
Pennsylvania and a Master of Business Administration degree from The
Robert E. McDonough School of Business at Georgetown University.

“Mihir’s significant experience and talents will add tremendous value to
our healthcare investment banking platform,” said J.P. Peltier, global
group head of healthcare investment banking at Piper Jaffray. “We are
very proud of our success in building a practice based on deep,
long-term and trusted relationships with our clients. Mihir’s dedication
to delivering the highest-caliber advice fits squarely within the Piper
Jaffray culture.”

Prior to joining Piper Jaffray, Scansaroli was a managing director and
co-head of healthcare equity capital markets at Barclays where he drove
significant growth in the Barclays life sciences equity practice.
Scansaroli previously served in healthcare equity capital markets at
Lehman Brothers, Inc. He earned a bachelor’s degree in accounting from
Boston College, and a Master of Business Administration degree from
Kenan-Flagler Business School at the University of North Carolina.

“Paul’s addition represents strategic growth to our healthcare capital
markets practice,” added David
, global head of equity capital markets at Piper Jaffray.
“We are thrilled to welcome him to our platform.”

The Piper Jaffray healthcare team remains one of the most highly
regarded investment banking practices on the street. The team is
comprised of over 100 advisory and capital markets professionals
delivering strategic advice and capital solutions to a broad array of
healthcare clients. Over the past 5 years, the Piper Jaffray healthcare
team has completed over 210 M&A assignments comprising approximately $60
billion in transaction value and over 200 bookrun capital markets
transactions, raising approximately $20 billion in equity and debt
capital. Piper Jaffray institutional research covers 205 public
companies in the healthcare space.

For further information on Piper Jaffray and the healthcare team, please

Piper Jaffray Companies (NYSE: PJC) is a leading investment bank and
institutional securities firm driven to help clients Realize the Power
of Partnership®. Securities brokerage and investment banking services
are offered in the U.S. through Piper Jaffray & Co., member SIPC and
FINRA; in Europe through Piper Jaffray Ltd., authorized and regulated by
the U.K. Financial Conduct Authority; and in Hong Kong through Piper
Jaffray Hong Kong Limited, authorized and regulated by the Securities
and Futures Commission. Asset management products and services are
offered through five separate investment advisory affiliates―U.S.
Securities and Exchange Commission (SEC) registered Advisory Research,
Inc., Piper Jaffray Investment Management LLC, PJC Capital Partners LLC
and Piper Jaffray & Co., and Guernsey-based Parallel General Partners
Limited, authorized and regulated by the Guernsey Financial Services

Follow Piper Jaffray: LinkedIn
| Facebook
| Twitter

© 2019 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000,
Minneapolis, Minnesota 55402-7036


Pamela Steensland
Tel: 612 303-8185
[email protected]